Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer.

Ludwig, Kathleen F

Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer. [electronic resource] - Cancer research 01 2018 - 246-255 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1538-7445

10.1158/0008-5472.CAN-17-1973 doi


Animals
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Benzocycloheptenes--administration & dosage
Carcinoma, Pancreatic Ductal--drug therapy
Cell Line, Tumor
Deoxycytidine--administration & dosage
Female
Humans
Male
Mice, Inbred C57BL
Mice, Transgenic
Molecular Targeted Therapy
Pancreatic Neoplasms--drug therapy
Protein Kinase Inhibitors--pharmacology
Proto-Oncogene Proteins--antagonists & inhibitors
Receptor Protein-Tyrosine Kinases--antagonists & inhibitors
Triazoles--administration & dosage
Xenograft Model Antitumor Assays
Gemcitabine
Axl Receptor Tyrosine Kinase